S'abonner

Left Ventricular Trabeculation: Arrhythmogenic and Clinical Significance in Elite Athletes - 03/06/24

Doi : 10.1016/j.echo.2024.03.003 
Giuseppe Di Gioia, MD a, b, c, , Simone Pasquale Crispino, MD b, Sara Monosilio, MD a, d, Viviana Maestrini, MD, PhD a, d, Antonio Nenna, MD, PhD e, Alessandro Spinelli, MD a, Erika Lemme, MD a, Maria Rosaria Squeo, MD a, Antonio Pelliccia, MD a
a Institute of Sports Medicine and Science, National Italian Olympic Committee, Rome, Italy 
b Department of Cardiovascular Sciences, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy 
c Department of Movement, Human and Health Sciences, University of Rome “Foro Italico,” Rome, Italy 
d Department of Clinical, Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy 
e Department of Heart Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy 

Reprint requests: Giuseppe Di Gioia, MD, Via Francesco Bartolomeo Rastrelli, 90-00128, Rome, Italy.Via Francesco Bartolomeo RastrelliRome90-00128Italy

Abstract

Introduction

Left ventricular (LV) trabeculations (LVTs) are common findings in athletes. Limited information exists regarding clinical significance, management, and outcome.

Objectives

The purpose of this study is to examine the prevalence and morphologic characteristics of LVTs in elite athletes, with a focus on clinical correlates and prognostic significance.

Methods

We enrolled 1,492 Olympic elite athletes of different sports disciplines with electrocardiogram, echocardiogram, and exercise stress test. Individuals with a definite diagnosis of LV noncompaction (LVNC) were excluded; we focused on athletes with LVTs not meeting the criteria for LVNC.

Results

Four hundred thirty-five (29.1%) athletes presented with LVTs, which were more frequent in male athletes (62.1% vs 53.5%, P = .002) and Black athletes compared with Caucasian (7.1% vs 2.4%, P < .0001) and endurance athletes (P = .0005). No differences were found with relation to either the site or extent of trabeculations. Endurance athletes showed a higher proportion of LVTs and larger LV volumes (end-diastolic and end-systolic, respectively, 91.5 ± 19.8 mL vs 79.3 ± 29.9 mL, P = .002; and 33.1 ± 10 mL vs 28.6 ± 11.7 mL, P = .007) and diastolic pattern with higher E wave (P = .01) and e’ septal velocities (P = .02). Ventricular arrhythmias were found in 14% of LVTs versus 11.6% of athletes without LVTs (P = .22). Neither the location nor the LVTs’ extension were correlated to ventricular arrhythmias. At 52 ± 32 months of follow-up, no differences in arrhythmic burden were observed (11.1% in LVT athletes vs 10.2%, P = .51).

Conclusions

Left ventricular trabeculations are quite common in athletes, mostly male, Black, and endurance, likely as the expression of adaptive remodeling. In the absence of associated clinical abnormalities, such as LV systolic and diastolic impairment, electrocardiogram repolarization abnormalities, or family evidence of cardiomyopathy, athletes with LVTs have benign clinical significance and should not require further investigation.

Le texte complet de cet article est disponible en PDF.

Central Illustration

Clinical (panel 1), functional (panel 2), and morphologic (panel 3) characteristics of LVTs in Olympic athletes. Panel 3 shows the distribution of LVTs according to their localization in anterior, lateral, inferior, and septal and involvement of basal, medium, or apical portion. According to results, LVTs can be considered as a benign condition, not requiring further investigations in most cases. ANT, Anterior; API, apical; BAS, basal; INF, inferior; MED, medium; LAT, lateral; SEP, septal.



Central Illustration : 

Clinical (panel 1), functional (panel 2), and morphologic (panel 3) characteristics of LVTs in Olympic athletes. Panel 3 shows the distribution of LVTs according to their localization in anterior, lateral, inferior, and septal and involvement of basal, medium, or apical portion. According to results, LVTs can be considered as a benign condition, not requiring further investigations in most cases. ANT, Anterior; API, apical; BAS, basal; INF, inferior; MED, medium; LAT, lateral; SEP, septal.


Central IllustrationClinical (panel 1), functional (panel 2), and morphologic (panel 3) characteristics of LVTs in Olympic athletes. Panel 3 shows the distribution of LVTs according to their localization in anterior, lateral, inferior, and septal and involvement of basal, medium, or apical portion. According to results, LVTs can be considered as a benign condition, not requiring further investigations in most cases. ANT, Anterior; API, apical; BAS, basal; INF, inferior; MED, medium; LAT, lateral; SEP, septal.

Le texte complet de cet article est disponible en PDF.

Highlights

LVTs may cause clinical concern in athletes.
LVTs are common findings (29%) mostly in male, Afro-Caribbean, and endurance athletes.
LVTs in this population represented an expression of adaptive remodeling in elite athletes.
In the absence of alert criteria, there is no negative prognostic value to LVTs.

Le texte complet de cet article est disponible en PDF.

Keywords : Trabeculations, Sports cardiology, Cardiomyopathies, Athlete's heart, Echocardiography

Abbreviations : BMI, BSA, CMR, ECG, ICC, LV, LVEF, LVNC, LVT, SCD, SVEB, TDI, TTE, VEB


Plan


© 2024  American Society of Echocardiography. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 37 - N° 6

P. 577-586 - juin 2024 Retour au numéro
Article précédent Article précédent
  • Information for Readers
| Article suivant Article suivant
  • Is It Finally Time to Untangle Elite Athletes From the Controversial Web of Left Ventricular Trabeculations?
  • Bradley S. Lander, Brian D. Hoit

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.